Navigation Links
Scientific Luminaries to Keynote at 3rd Annual PODD
Date:6/12/2013

New York, New York (PRWEB) June 12, 2013

The Conference Forum is pleased to announce the keynotes for the 3rd annual PODD: Partnership Opportunities in Drug Delivery event, which takes place on October 10-11 in Boston. PODD is strategic level networking event designed to bring drug delivery innovators together with key decision makers at pharmaceutical, biotechnology and medical device companies. This event provides the opportunity to learn about cutting-edge delivery technologies and meet with senior level executives and scientists.

To kick-off the PODD event, Robert Langer, PhD, David H. Koch Institute Professor at MIT will engage in a fireside style chat to discuss the difference between success and failure of drug delivery technologies.

On the second day of the conference George M. Whitesides, PhD, Woodford L. and Ann A. Flowers University Professor, Harvard University and Founding Core Faculty Member, Wyss Institute will address how drug delivery will disrupt the future of healthcare.

PODD is chaired by Barbara Lueckel, PhD, Global Business Development Director, Roche and features a wide range of drug delivery technologies, pharmaceutical and biotech business development panels, together with new discussions related to delivering biologics, role of drug delivery in the R&D pipeline, nanomedicine, and funding in the drug delivery sector.

We are excited to bring all the major components together that advance drug delivery partnerships," Valerie Bowling, Executive Director of the Conference Forum.

Other conference highlights include:
    ?    How drug delivery is disrupting the diagnostics industry
    ?    Who is funding drug delivery
    ?    The next paradigm on how biologics will be delivered
    ?    New deal structures and models
    ?    POV from heads of R&D on the role of drug delivery
    ?    Partnering and networking tools and facilities

To learn more about the PODD conference, visit http://www.theconferenceforum.org.

About the Conference Forum

The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. We currently offer conferences for R&D leaders, Clinical Development professionals, young and established Biotech executives, and Drug Delivery specialists. Our mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals.

Related Links:
Dr Robert S. Langer, PhD, Biography
Dr George Whitesides, PhD, Biography
Barbara Lueckel, PhD, Biography

Read the full story at http://www.prweb.com/releases/2013/6/prweb10813366.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Steep Hill Laboratories and Halent Scientific Proudly Announce Historic Merger
2. Used Scientific Equipment Supplier, BMI Surplus, Partners with Universities During Sequester
3. Hemostemix Announces Formation of Scientific Advisory Board
4. DuPont Celebrates Scientific Innovation by Recognizing Young Professors
5. Pioneering Researchers Recognized for Scientific Achievements in Gene and Cell Therapy
6. Trigemina Presents at American Pain Society 32nd Annual Scientific Meeting
7. Emory Cardiologists Arshed Quyyumi And Javed Butler Join Stemedica Cardiology Division Scientific Advisory Board
8. Amarin, Pharmacyclics, Anthera Pharma, Star Scientific, and Impax Laboratories Under StockCalls Microscope
9. Heptares to Present at Upcoming Scientific and Biotech Industry Conferences
10. “Scientific And Medical Research On The Successful Treatment Of Type 1 + 2 Diabetes With Alkaline Reduced Water” is Reviewed in Today’s Bawell Water Ionizer Health Report
11. BioRestorative Therapies Announces Chairman of Its Scientific Advisory Board to Speak at Vatican
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... ... to immediately determine the adulterants which pose the most likely threat to their ... 28 of this year. , IFT's annual food expo attracts over 20,000 ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... ... for discovery of antibody therapeutics from millions-diverse immune repertoires, announces launch of its ... San Diego, California. Dave Johnson, PhD, CEO of GigaGen, will present on Surge ...
(Date:6/19/2017)... ... June 19, 2017 , ... A colony of healthy honey bees is ... by delivering pollen and nectar containing nutrients necessary for growth and survival. Better nutrition ... Many recent indicators point to a decline in honey bee health. Sick and weakened ...
(Date:6/15/2017)... ... June 15, 2017 , ... New resistant soybean and cotton ... managing Palmer amaranth and other broadleaf weeds resistant to glyphosate. But scientists with ... herbicides are known to drift and to cause harm to sensitive, off-target broadleaf ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)... HONG KONG , March 30, 2017 ... developed a system for three-dimensional (3D) fingerprint identification by adopting ground ... technology into a new realm of speed and accuracy for use ... applications at an affordable cost. ... ...
Breaking Biology News(10 mins):